相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer
Tien-Yi Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
Saro Kasparian et al.
ONCOLOGIST (2023)
Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion
Daniel Gorovets et al.
EUROPEAN UROLOGY ONCOLOGY (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Amar U. Kishan et al.
LANCET ONCOLOGY (2022)
Patient participation in treatment decision-making of prostate cancer: a qualitative study
Shucheng Pan et al.
SUPPORTIVE CARE IN CANCER (2022)
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium
Amar U. Kishan et al.
EUROPEAN UROLOGY (2022)
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Tamir N. Sholklapper et al.
FRONTIERS IN ONCOLOGY (2022)
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study
Irving Kaplan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Androgen deprivation therapy and cardiovascular disease
Chiara Melloni et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial
David P. Dearnaley et al.
EUROPEAN UROLOGY (2020)
Relugolix: Early Promise for a Novel Oral Androgen Deprivation Therapy with Radiation Therapy for Prostate Cancer
Sean Sachdev et al.
EUROPEAN UROLOGY (2020)
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Neal D. Shore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The fear of needles: A systematic review and meta-analysis
Jennifer McLenon et al.
JOURNAL OF ADVANCED NURSING (2019)
Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer
Johanna Wassermann et al.
CANCER (2019)
Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer
Bruno Nascimento et al.
JOURNAL OF SEXUAL MEDICINE (2019)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U. Kishan et al.
JAMA NETWORK OPEN (2019)
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation
Fady B. Geara et al.
RADIATION ONCOLOGY (2017)
Androgen Deprivation Therapy and Dose-Escalated Radiotherapy for Intermediate-and High-Risk Prostate Cancer Reply
Aaron D. Falchook et al.
JAMA ONCOLOGY (2017)
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy A Secondary Analysis of a Randomized Clinical Trial
Trevor J. Royce et al.
JAMA ONCOLOGY (2017)
Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males
David B. MacLean et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Impact of Neoadjuvant Prostate-Specific Antigen Kinetics on Biochemical Failure and Prostate Cancer Mortality: Results From a Prospective Patient Database
Marcus Foo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Leonard N. Chen et al.
RADIATION ONCOLOGY (2013)
Testosterone in prostate cancer: the Bethesda consensus
Bob Djavan et al.
BJU INTERNATIONAL (2012)
Gonadotropin-releasing hormone: An update review of the antagonists versus agonists
Hein Van Poppel et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials
Anthony V. D'Amico et al.
LANCET ONCOLOGY (2012)
EXTERNAL BEAM RADIOTHERAPY FOR PROSTATE CANCER: URINARY OUTCOMES FOR MEN WITH HIGH INTERNATIONAL PROSTATE SYMPTOM SCORES (IPSS)
Renuka Malik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
A COMPARISON OF THE PROGNOSTIC VALUE OF EARLY PSA TEST-BASED VARIABLES FOLLOWING EXTERNAL BEAM RADIOTHERAPY, WITH OR WITHOUT PRECEDING ANDROGEN DEPRIVATION: ANALYSIS OF DATA FROM THE TROG 96.01 RANDOMIZED TRIAL
David S. Lamb et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
James W. Denham et al.
LANCET ONCOLOGY (2011)
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Androgen suppression and radiation vs radiation alone for prostate cancer - A randomized trial
Anthony V. D'Amico et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Failure to achieve a PSA level ≤1 ng/mL after neoadjuvant LHRHa therapy predicts for lower biochemical control rate and overall survival in localized prostate cancer treated with radiotherapy
Darren M. Mitchell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Gonadotropin-releasing hormone agonists in the treatment of prostate cancer
F Labrie et al.
ENDOCRINE REVIEWS (2005)